Institution
Fudan University Shanghai Cancer Center
Also known as: FUSCC
- 562running trials
- 112closed trials
- 1researcher
- 21,625publications (OpenAlex)
Researchers
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
Recruiting
Not yet recruiting
Not yet recruiting
Phase III Study of HS-20089 With Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer
Recruiting
Not yet recruiting
Not yet recruiting
A Phase 3 Study of Deutenzalutamide in Patients With High-Risk BCR Prostate Cancer
Not yet recruiting
Not yet recruiting
Lymph Node Dissection After Neoadjuvant Therapy for Gastric and EGJ Adenocarcinoma
Not yet recruiting
Not yet recruiting
Recruiting
Becotatug Vedotin Plus Pucotenlimab for Metastatic Colorectal Cancer
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
AXT-1003 Combination With Enzalutamide in Participants With mCRPC
Not yet recruiting
Recruiting
Recruiting
Cetuximab Combined With Pembrolizumab or Finotonlimab and Chemotherapy in R/M HNSCC
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Standardized MRI and Structured Reporting for Esophageal Squamous Cell Carcinoma
Not yet recruiting
Recruiting
A Clinical Study of SYS6041 Combination Therapy for Recurrent Ovarian Cancer
Recruiting
Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases
Not yet recruiting
Response-adapted Postoperative Radiotherapy In Locally Advanced Head and Neck Cancer
Recruiting
A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate Cancer
Recruiting
A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours
Recruiting
Recruiting
Recruiting
A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer
Recruiting
PD-1 Inhibitors Combined With Local Therapy at Different Timings in Oligometastatic ESCC
Not yet recruiting
Sacituzumab Tirumotecan vs MMAE-ADCs in Advanced Urothelial Carcinoma (FUSCC-SPARE-UC-01)
Active, not recruiting
Recruiting
Not yet recruiting
Recruiting
Showing 50 of 562.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer67 recruiting
- Lung cancer63 recruiting
- Gastric and oesophageal cancer50 recruiting
- Metastatic breast cancer50 recruiting
- Pancreatic cancer36 recruiting
- Prostate cancer29 recruiting
- Ovarian cancer25 recruiting
- Triple-negative breast cancer25 recruiting
- Bladder cancer19 recruiting
- Liver and biliary tract cancer16 recruiting
- Cervical cancer14 recruiting
- Childhood cancers14 recruiting
- Head and neck cancer14 recruiting
- Diffuse large B-cell lymphoma13 recruiting
- Endometrial cancer12 recruiting
- Brain metastases11 recruiting
- Melanoma9 recruiting
- Chronic lymphocytic leukaemia7 recruiting
- Neuroendocrine tumours7 recruiting
- Thyroid cancer7 recruiting
- Kidney cancer6 recruiting
- Mantle cell lymphoma6 recruiting
- Sarcoma6 recruiting
- Acute lymphoblastic leukaemia2 recruiting
- Follicular lymphoma2 recruiting
- Mesothelioma2 recruiting
- Thymoma and thymic carcinoma2 recruiting
- Hodgkin lymphoma1 recruiting
Closed trials
Completed
Completed
Feasibility of a Nurse-Supported Mobile App for Self-Help CBT-I in Cancer Caregivers
Completed
Completed
ProSight: A Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Study of AK104 Monotherapy or AK104 Plus Axitinib in Advanced/Metastatic Renal Cell Carcinoma
Terminated
Evaluate the Efficacy, Safety and Tolerability of HLX26 and Serplulimab in Patients with MCRC
Completed
Completed
Completed
Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer
Withdrawn
EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung Cancer
Terminated
Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma
Completed
Completed
Completed
Completed
Terminated
A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced Pancreatic Cancer
Completed
Completed
Completed
Completed
Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Completed
Completed
Terminated
A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy
Completed
Real-world Experience of ICIs Plus Chemotherapy for Advanced ESCC.
Completed
Completed
Terminated
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets
Completed
Completed
Completed
Completed
Completed
Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma
Completed
Terminated
APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma
Completed
Completed
Showing 50 of 112.
Registry name variants (59)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Fudan University Shanghai Cancer Center
Shanghai, 200032
590 trials
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Shanghai, Shanghai Municipality 200032
8 trials
Fudan University - Shanghai Cancer Center (FUSCC)
Shanghai, 200032
6 trials
Department of Pancreatic Surgery,Fudan University Shanghai Cancer Center
Shanghai, Xuhui 200032
4 trials
Fudan university shanghai cancer center, Deparment of gynecologic oncology
Shanghai, Shanghai Municipality 200032
3 trials
NCT06548763Oral Topotecan With Toripalimab for Patients With Endometrial Cancer
Contact: Hao Wen, MD
NCT06552858Fluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian Cancer
Contact: Xingzhu Ju, MD
Contact: Hao Wen
Fudan University Shanghai Cancer Center - Oncology Department
Shanghai, Shanghai Municipality 200000
2 trials
Fudan University Shanghai Cancer Center, Shanghai,
Shanghai
2 trials
Contact: Tong Li, PHD
Contact: Jinglin Xu
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Shanghai, Shanghai Municipality 200032
2 trials
Contact: Zhimin Shao, M.D.
Contact: Zhimin Shao, M.D.
Fudan University Shanghai Cancer Center (Site 0160)
Shanghai, Shanghai Municipality 201315
2 trials
Fudan University Shanghai Cancer Center (Site 0607)
Shanghai, Shanghai Municipality 200032
2 trials
Fudan University Shanghai Cancer Center (Site 1176)
Shanghai, Shanghai Municipality 201321
2 trials
Fudan University Shanghai Cancer Center (Site 2500)
Shanghai, Shanghai Municipality 200032
2 trials
Fudan University Shanghai Cancer Center (Site 2908)
Shanghai, Shanghai Municipality 200032
2 trials
Fudan University Shanghai Cancer Center (Site 3324)
Shanghai, Shanghai Municipality 200032
2 trials
Fudan University Shanghai Cancer Centre
Shanghai, Shanghai Municipality 200032
2 trials
NCT07793318TR115 in ARID1A-Mutated Advanced Solid Tumors
Contact: Xiaohua Wu, MD, PhD
NCT04221542Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Shanghai Cancer Center, Fudan University
Shanghai, 200030
2 trials
270 Dongan Road, Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality 200032
1 trial
Contact: Dawei Li, PhD
Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality 200032
1 trial
NCT06965231Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial
Contact: Chunmeng Wang, Dr.
Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Shanghai, Shanghai Municipality 200032
1 trial
NCT06166147A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
Contact: Xian-Jun Yu, M.D., Ph.D.
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center Shanghai, Shanghai, China
Shanghai, Shanghai Municipality
1 trial
Fudan University Shanghai Cancer Center
Henan, 450008
1 trial
Fudan University Shanghai Cancer Center
Shanghai Shi, 200032
1 trial
Fudan University Shanghai Cancer Center
Shanhai
1 trial
NCT06359275PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients
Contact: Weijing Zhang
Fudan University Shanghai Cancer Center
Xuhui, Shanghai Municipality 200032
1 trial
Fudan University Shanghai Cancer Center
Xuhui District
1 trial
Fudan University Shanghai Cancer Center - Gynecologic Oncology
Shanghai, Shanghai Municipality
1 trial
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality 200032
1 trial
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality 200032
1 trial
Fudan University Shanghai Cancer Center; Medical Oncology
Shanghai, 201315
1 trial
Fudan University Shanghai Cancer Center, Shanghai, Shanghai 200032
Shanghai, Shanghai Municipality 200032
1 trial
Contact: Keda Yu Professor
Fudan University Shanghai Cancer Center (Site 0024)
Shanghai, Shanghai Municipality 200032
1 trial
Fudan University Shanghai Cancer Center (Site 0086)
Shanghai, Shanghai Municipality 200032
1 trial
Fudan University Shanghai Cancer Center (Site 0161)
Shanghai, Shanghai Municipality 200032
1 trial
Fudan University Shanghai Cancer Center (Site 0181)
Shanghai, Shanghai Municipality 200032
1 trial
Contact: Study Coordinator
Fudan University Shanghai Cancer Center (Site 0304)
Shanghai, Shanghai Municipality 200032
1 trial
Fudan University Shanghai Cancer Center (Site 0401)
Shanghai, Shanghai Municipality 200120
1 trial
Fudan University Shanghai Cancer Center (Site 0504)
Shanghai, Shanghai Municipality 200030
1 trial
NCT07634471A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Contact: Study Coordinator
Fudan University Shanghai Cancer Center (Site 0520)
Shanghai, Shanghai Municipality 200032
1 trial
Fudan University Shanghai Cancer Center (Site 0721)
Shanghai, Shanghai Municipality 200032
1 trial
Fudan University Shanghai Cancer Center (Site 0813)
Shanghai, Shanghai Municipality 200032
1 trial
Fudan University Shanghai Cancer Center (Site 0816)
Shanghai, Shanghai Municipality 200120
1 trial
Contact: Study Coordinator
Fudan University Shanghai Cancer Center (Site 1208)
Shanghai, Shanghai Municipality 200032
1 trial
Fudan University Shanghai Cancer Center (Site 1400)
Shanghai, Shanghai Municipality 200032
1 trial
Contact: Study Coordinator
Fudan University Shanghai Cancer Center (Site 1606)
Shanghai, Shanghai Municipality 200032
1 trial
Fudan University Shanghai Cancer Center (Site 1711)
Shanghai, Shanghai Municipality 200032
1 trial
NCT07519772A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Contact: Study Coordinator
Fudan University Shanghai Cancer Center (Site 2137)
Shanghai, Shanghai Municipality 200032
1 trial
Contact: Study Coordinator
Fudan University Shanghai Cancer Center (Site 2209)
Shanghai, Shanghai Municipality 200000
1 trial
Contact: Study Coordinator
Fudan University Shanghai Cancer Center (Site 2216)
Shanghai, Shanghai Municipality 200032
1 trial
Contact: Study Coordinator
Fudan University Shanghai Cancer Center (Site 2424)
Shanghai, Shanghai Municipality 200032
1 trial
Fudan University Shanghai Cancer Center (Site 2801)
Shanghai, Shanghai Municipality 200032
1 trial
Contact: Study Coordinator
Fudan University Shanghai Cancer Center (Site 3009)
Shanghai, Shanghai Municipality 200032
1 trial
Fudan University Shanghai Cancer Center (Site 3115)
Shanghai, Shanghai Municipality 200032
1 trial
Contact: Study Coordinator
Fudan University Shanghai Cancer Center (Site 3144)
Shanghai, Shanghai Municipality 200032
1 trial
Fudan University Shanghai Cancer Center (Site 5513)
Shanghai, Shanghai Municipality 200032
1 trial
Fudan University Shanghai Cancer Center (Site 7513)
Shanghai, Shanghai Municipality 200032
1 trial
Contact: Study Coordinator
Fudan University Shanghai Cancer Center/Thoracic Oncology Department
Shanghai, Shanghai Municipality 200032
1 trial
Contact: Jialei Wang, Site 007-035-Ph3
Fudan University Shanghai Cancer Center - Xuhui Campus
Shanghai, Shanghai Municipality
1 trial
Contact: Astellas Pharma Global Development, Inc.
Fudan University Shanghai Cancer Center - Xuhui District
Shanghai, 200032
1 trial
Second Department of Gastric Surgery, Fudan University Shanghai Cancer Center,
Shanghai
1 trial
Contact: FengLin Liu, doctor
Conditions
Diseases this institution publishes on or runs trials for.
- Lung cancer151 works · 117 trials
- Colorectal cancer126 works · 85 trials
- Liver and biliary tract cancer106 works · 33 trials
- Gastric and oesophageal cancer100 works · 75 trials
- Triple-negative breast cancer88 works · 36 trials
- Ovarian cancer82 works · 35 trials
- Prostate cancer81 works · 43 trials
- Pancreatic cancer52 works · 55 trials
- Metastatic breast cancer37 works · 79 trials
- Brain metastases32 works · 15 trials
- Bladder cancer31 works · 32 trials
- Sarcoma31 works · 9 trials
- Kidney cancer27 works · 14 trials
- Neuroendocrine tumours26 works · 14 trials
- Cervical cancer26 works · 20 trials
- Diffuse large B-cell lymphoma19 works · 20 trials
- Thyroid cancer19 works · 12 trials
- Endometrial cancer18 works · 17 trials
- Head and neck cancer13 works · 22 trials
- Follicular lymphoma9 works · 11 trials
- Thymoma and thymic carcinoma6 works · 2 trials
Institution data: ROR 00my25942 (CC0-1.0)Updated 15 Nov 2026